Thiogenesis Therapeutics, Corp. TTIPF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.08M | -664.70K | -1.24M | -1.73M | -1.37M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 56.00K | 85.00K | 95.10K | 216.10K | 155.90K |
| Change in Net Operating Assets | -418.00K | 64.50K | -220.40K | -27.40K | 369.90K |
| Cash from Operations | -1.44M | -515.30K | -1.37M | -1.54M | -847.10K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 8.38M | -- | 0.00 | 3.81M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 6.05M | -- | 0.00 | 2.77M | -- |
| Foreign Exchange rate Adjustments | -12.10K | -4.10K | 14.60K | -21.00K | 800.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.60M | -519.40K | -1.35M | 1.20M | -846.40K |